Chapter review

Fitzgerald PMHNP board review. ch15. Disorders of Children and Adolescents. This is drive 2 of 4. When I say Pause. Answer. wait, then I will give the answer. New section. ADHD, ASD, and disruptive behavior: criteria, age gates, and first-line. Topic. Table 15-17: Disruptive and Impulse-Control Treatments. Bottom Line Summary. * **Oppositional Defiant Disorder (ODD)** requires an 8-month or at least 6-month pattern of irritable mood, argumentative behavior, defensiveness, and vindictiveness toward authority figures [1, 2]. * **First-line** treatment for ODD is family behavioral therapy; psychotropic medications like SSRIs are not indicated as primary treatment [3, 4]. * **Conduct Disorder (CD)** requires a persistent pattern of behavior violating the basic rights of others or major societal rules across four core categories: aggression to people/animals, destruction of property, deceitfulness or theft, and serious violations of rules [5-7]. * **Board trap**: Poor academic performance is a functional consequence of disruptive behavior, NOT a core diagnostic criterion for Conduct Disorder or ODD [6, 7]. * Treatment for Conduct Disorder combines social skills training and family education; severe cases may require out-of-home placement in a group home or intensive residential facility source 8. * Dietary modifications, such as limiting refined carbohydrates, have no evidence-based role in treating disruptive behavior disorders [3, 9]. Core Clinical Teaching: Disruptive and Impulse-Control Disorders. When evaluating children and adolescents with disruptive behaviors, board exams test your ability to differentiate Oppositional Defiant Disorder from Conduct Disorder based on behavioral boundaries and safety risks [2, 4]. Both conditions cause significant social and behavioral disruption, but they differ in symptom severity, violation of societal norms, and intervention intensity [2, 4, 6]. Oppositional Defiant Disorder involves persistent verbal defiance, hostility, and emotional dysregulation directed at parents, teachers, and authority figures [1, 2]. Key features include losing temper, arguing with adults, actively refusing to comply with requests, deliberately annoying others, blaming peers for personal mistakes, and becoming defensive when corrected [1, 2]. **First-line** intervention for ODD is family behavioral therapy [3, 4]. Prescribing psychotropic medications such as SSRIs is inappropriate as an initial strategy, and advising parents that the child will outgrow the behavior delays necessary evidence-based care [3, 4, 9]. **Board trap**: Exam stems frequently mention that a child with ODD or Conduct Disorder is failing in school or performing poorly academically [1, 5]. Test writers use this to distract candidates into selecting learning disability workups or academic accommodations instead of recognizing the primary disruptive behavior diagnosis [3, 6, 7]. Academic performance is an associated impairment rather than a diagnostic criterion [6, 7]. Conduct Disorder represents a more severe clinical entity characterized by rights violations, lawbreaking, and physical harm [4, 7]. Diagnostic criteria fall into four explicit categories: 1. Aggression toward people and animals [5, 7] 2. Destruction of property [5, 7] 3. Deceitfulness or theft [5, 7] 4. Serious rule violations, such as truancy or running away [5, 7] **Safety alert**: Conduct Disorder involves dangerous behaviors like physical cruelty, weapon use, arson, and property destruction [5, 7]. Management requires social skills training and structured family education source 8. When safety cannot be maintained in the home environment, clinicians must coordinate out-of-home placement in a specialized group home or residential treatment setting source 8. Fitzgerald Sample Test Questions. Question 9. Peter is a healthy 7-year-old second grader who lives with his 4-year-old sister and his parents. He is brought to the clinic by his parents, who are concerned about an 8-month history of behavioral issues. He has an explosive temper, argues with his parents, and blames others for his mistakes. The teacher reports that he often does not follow directions, and when corrected, he becomes defensive and argumentative. The teacher witnessed him repeatedly prod a pencil into a classmate's bag. When he was confronted about this, he denied doing it. You consider the most appropriate course of action is: A. Start therapy with an SSRI B. Initiate family behavioral therapy C. Suggest limiting refined carbohydrates from his diet D. Advise the family that children of this age often outgrow this type of behavior Pause. Answer: B source 3 Why It Is Correct. The child exhibits classic symptoms of Oppositional Defiant Disorder (ODD), including an explosive temper, arguing with adults, blaming others, and becoming defensive when corrected over an 8-month duration [1-3]. Family behavioral therapy is the evidence-based **first-line** treatment for ODD [3, 4]. Why the Other Choices Are Wrong. * **A:** SSRIs have no role as primary pharmacotherapy for Oppositional Defiant Disorder [3, 9]. * **C:** Dietary restrictions like eliminating refined carbohydrates lack clinical evidence and do not address behavioral pathology [3, 9]. * **D:** ODD requires active behavioral intervention; dismissing it as a normal stage delays necessary treatment [3, 4, 9]. Question 14. Clinical features supporting the diagnosis of Conduct Disorder in a 14-year-old boy include all of the following EXCEPT: A. Theft B. Aggression to animals C. Destruction of property D. Poor academic performance Pause. Answer: D source 6 Why It Is Correct. Poor academic performance is a potential downstream functional consequence of disruptive behavior, but it is not one of the diagnostic criteria for Conduct Disorder [6, 7]. Why the Other Choices Are Wrong. * **A:** Theft and deceitfulness form one of the four main diagnostic criterion categories for Conduct Disorder [5-7]. * **B:** Aggression to people and animals is a core diagnostic criterion category [5-7]. * **C:** Destruction of property is a core diagnostic criterion category [5-7]. Next. New section. Pediatric Depression and DMDD. Topic. Standardized Assessment for Youth Mood. Bottom Line Summary. * **Major Depressive Disorder** in youth frequently manifests as irritable mood or feeling "mad at the world" rather than classic sadness, along with failure to make expected developmental weight gains, initial insomnia, or after-school fatigue. * Only two antidepressants are FDA approved for pediatric depression: **fluoxetine** for patients aged 8 years and older, and **escitalopram** for patients aged 12 years and older. * All antidepressants carry an FDA Black Box warning for an increased risk of suicidal thoughts and behaviors in children, adolescents, and young adults up to age 24. * **Disruptive Mood Dysregulation Disorder** requires chronic, severe persistent irritability with temper outbursts occurring at least 3 times per week for over 12 months, with symptom onset before age 10 years and manifestation across at least 2 settings. * Youth diagnosed with **Major Depressive Disorder** carry a 20% to 40% risk of developing bipolar disorder, with higher risk linked to prepubertal onset, a multigenerational family history of mood disorders, or psychotic features. * Standardized mood and psychosocial screening tools include the **PHQ-A** (modified PHQ-9 for adolescents), the **Pediatric Symptom Checklist** (PSC-17 or PSC-35), the **Vanderbilt** screening tool, and the **HEADS** mnemonic. Standardized Assessment and Clinical Management of Youth Mood. Standardized Screening Tools for Pediatric Mood and Behavioral Assessment. * **PHQ-A**: Modified Patient Health Questionnaire for adolescents used to screen for and monitor depressive symptom severity. * **Pediatric Symptom Checklist**: Available as PSC-17 or PSC-35, used as a broad pre-visit screening tool sent to parents and teachers prior to the initial consultation to evaluate emotional and behavioral domains. * **Vanderbilt Screening Tool**: Completed by both parents and teachers to assess symptoms across domains of inattention, disruption, behavior, anxiety, depression, and academic performance. * **HEADS Mnemonic**: A structured psychosocial assessment framework for adolescents covering **H**ome, **E**ducation and future plans, **A**ctivities, **D**rugs and alcohol use, **S**ex and sexuality, and **S**uicidality or mental health concerns. Diagnostic Criteria and Clinical Features. * **Major Depressive Disorder**: * Presentation in youth often features marked irritability, social withdrawal, drop in grades, somatic complaints, and failure to make expected developmental weight gains. * Up to 20% to 40% of pediatric patients with **Major Depressive Disorder** eventually develop bipolar disorder. * **Disruptive Mood Dysregulation Disorder**: * Diagnostic threshold: Severe, recurrent temper outbursts out of proportion to the situation, occurring 3 or more times per week for at least 12 months without a symptom-free period exceeding 3 consecutive months. * Age gates: Onset of symptoms must occur before age 10 years, and the diagnosis should not be made for the first time before age 6 years or after age 18 years. * Setting requirement: Symptoms must be present in at least 2 settings (such as home, school, or with peers) and severe in at least 1 setting. Treatment Principles and Safety Standards. * **First-line**: Psychotherapy such as cognitive behavioral therapy or interpersonal therapy is a primary first-line intervention. When pharmacotherapy is indicated, **fluoxetine** (approved for age 8 and older) or **escitalopram** (approved for age 12 and older) is the **first-line** choice. * **Safety alert**: Monitor youth closely for suicidal ideation, behavioral activation, or agitation during the initial 1 to 2 months of starting antidepressant therapy due to the FDA Black Box warning for suicidality in individuals under age 25. * **Board trap**: Do not select tricyclic antidepressants for pediatric depression. They are ineffective in children and carry a high risk of lethal cardiac arrhythmias in overdose. * **Board trap**: Do not confuse **Disruptive Mood Dysregulation Disorder** with bipolar disorder. **Disruptive Mood Dysregulation Disorder** features persistent, non-episodic irritability between temper outbursts, whereas bipolar disorder presents with distinct episodic shifts in mood, energy, and grandiosity. Sample Practice Questions. Question 5. Katana, a 14-year-old girl evaluated in your clinic, meets the diagnostic criteria for **Major Depressive Disorder**. Which of the following is true regarding depression treatment in children and adolescents? A. **Fluoxetine** is one of only two medications FDA approved for use with adolescents. B. Children require lower doses of antidepressants than adults. C. Psychopharmacology is more effective than psychotherapy. D. Tricyclic antidepressants offer a reasonable second-line option. Pause. Answer: A. Why it is correct: **Fluoxetine** (approved for ages 8 and older) and **escitalopram** (approved for ages 12 and older) are the only two FDA-approved antidepressants for pediatric and adolescent depression. Why the other choices are wrong: * A. Correct choice. * B. Children often metabolize medications rapidly through hepatic pathways and may require standard adolescent or adult dosing rather than lower doses. * C. Psychotherapy, particularly cognitive behavioral therapy, is highly effective in youth and is often as effective as or more effective than psychopharmacology alone. * D. Tricyclic antidepressants are not recommended as second-line agents in pediatrics due to lack of efficacy and severe cardiotoxicity risks. Question 15. During an evaluation of a 16-year-old female with a substance use disorder, she confides that she is increasingly confused about her sexual orientation. What is the appropriate action by the PMHNP? A. Notify her parents of this finding. B. Routinely screen for depression and suicidality. C. Initiate reparative therapy. D. Initiate SSRI therapy. Pause. Answer: B. Why it is correct: Adolescents questioning their sexual orientation or experiencing gender role ambiguity face elevated stress and health disparities, placing them at increased risk for co-occurring **Major Depressive Disorder** and suicidal ideation. Routine screening for mood symptoms and suicide risk is the essential clinical priority. Why the other choices are wrong: * A. Disclosing a confidential discussion regarding sexual orientation to parents without the minor's consent violates trust and may compromise the patient's home safety. * B. Correct choice. * C. Conversion or reparative therapy is unethical, harmful, and rejected by national professional healthcare organizations. * D. Initiating psychotropic medication is premature without a diagnosed psychiatric disorder such as **Major Depressive Disorder** or an anxiety disorder. Next Study Step. * Proceed to the next pediatric topic in Chapter 15 covering Attention Deficit Hyperactivity Disorder (ADHD) and pediatric stimulant management to compare neurodevelopmental and behavioral presentations across settings. Next. New section. Mood, anxiety, OCD, and trauma presentations unique to youth. Topic. Anxiety Disorders and Separation Nuances. Anxiety Disorders and Separation Nuances. Bottom Line. - Stranger anxiety is a normal developmental milestone that emerges between **8 to 10 months**, peaking around **9 months** of age. - **Separation anxiety disorder** requires at least **3 or more** persistent symptoms lasting at least **4 weeks** in children and adolescents, or **6 months or more** in adults, with onset before **18 years of age** (and can begin before **6 years of age**). - **Functional capacity** is the core clinical metric that distinguishes **separation anxiety disorder** from age-appropriate developmental fears. - **First-line** treatment for **separation anxiety disorder** is **psychotherapy** (such as cognitive behavioral therapy, play therapy, or family behavioral therapy), not psychotropic medications. - **SSRIs** are not the **first-line** intervention for **separation anxiety disorder** in young children and should be reserved for severe or refractory cases. - Initial clinical evaluations for a child under **6 years of age** with suspected separation anxiety should keep parents present to avoid overwhelming panic and allow observation of parent-child interactions. - Severe somatic responses to separation, such as crying fits that progress to choking or vomiting in a 5-year-old, represent pathological impairment requiring formal diagnostic evaluation. Must Know for Boards. Diagnostic Boundaries and Timelines. **Separation anxiety disorder** involves excessive fear or anxiety concerning separation from attachment figures that is developmentally inappropriate. Diagnostic criteria require at least **3 or more** persistent symptoms. In youth, symptoms must last for at least **4 weeks**, whereas in adults, the required duration is **6 months or more**. Onset must occur before **18 years of age**, though early symptoms frequently emerge before **6 years of age**. Clinical Features. Core manifestations include excessive distress when anticipating or experiencing separation from home or attachment figures, persistent worry about losing or harm coming to attachment figures, refusal to attend school or go away from home, reluctance to sleep away from primary caregivers, repeated separation-themed nightmares, and physical somatic complaints like **headaches**, **stomachaches**, **nausea**, and **vomiting** when separation occurs or is anticipated. Key Signposts. - **First-line**: **Psychotherapy** (cognitive behavioral therapy, play therapy, or family therapy) is the **first-line** treatment for **separation anxiety disorder**. Medications like **SSRIs** are second-line. - **Safety alert**: Severe physical symptoms like crying fits leading to choking or vomiting when facing routine separation indicate profound functional distress. Do not dismiss these as normal developmental phases. - **Board trap**: Forcing a young child under **6 years of age** to be interviewed alone during an initial evaluation for separation anxiety. Separating the child from parents during the initial visit causes intense panic and invalidates the assessment. High-Yield Concepts and Spoken Teaching. Normal Development versus Pathological Anxiety. Developing children experience predictable developmental fears. Stranger anxiety begins around **8 to 10 months** and peaks at **9 months**. Mild hesitancy when separating from parents at school entry can occur normally. Clinicians must evaluate **functional capacity** to determine if anxiety is pathological. If anxiety prevents school attendance, impairs peer interactions, or triggers severe somatic distress like choking and vomiting, it crosses the threshold into **separation anxiety disorder**. Spoken Teaching on Diagnostic Criteria. When evaluating **separation anxiety disorder** for board exams, remember that the core issue is developmentally inappropriate and excessive fear of losing attachment figures. The DSM-5-TR requires at least **3 key symptoms** present for at least **4 weeks** in children under **18 years of age**. Early onset often appears before **6 years of age**. Look for stems describing school refusal, refusal to sleep alone, nightmares about separation, and somatic complaints occurring every Sunday night before school or every morning before drop-off. Interviewing Strategies for Young Anxious Children. When evaluating a 4-year-old or 5-year-old child for separation anxiety, begin the interview with the parents present in the room. Observe the parent-child interaction, motor development, and social responsiveness. Use indirect assessment techniques such as play, puppets, or drawing to engage the child. Forcing an isolated child interview during the initial visit for separation anxiety increases distress and prevents effective rapport building. Board-Style Practice Questions. Question 1. Stranger anxiety typically occurs at approximately what age? - A. 4 months old - B. 6 months old - C. 9 months old - D. 16 months old Pause. Answer: C. Why it is correct: Stranger anxiety is a normal developmental milestone that emerges between 8 to 10 months of age, peaking around 9 months. Why the other choices are wrong: - A. At 4 months, infants have not developed object permanence or stranger discrimination. - B. At 6 months, social engagement is active, but stranger fear has not yet peaked. - D. At 16 months, toddlers are in a mobile exploration phase beyond the initial peak of stranger anxiety. Test-taking pearl: Memorize normal developmental milestone timing to distinguish normal growth from early pathology. Concept tested: Pediatric developmental milestones Question 2. When evaluating a 4-year-old boy during an initial visit for signs of separation anxiety disorder, appropriate techniques include all of the following except: - A. Ensure the child is interviewed separately from parents - B. Observe behaviors and play - C. Utilize puppets and dolls during the interview process - D. Assess motor development and problem solving skills Pause. Answer: A. Why it is correct: Forcing an interview separate from parents in a 4-year-old presenting with separation anxiety causes severe panic and invalidates the assessment. Why the other choices are wrong: - B. Observing play and parent-child interactions yields essential diagnostic data. - C. Utilizing puppets and dolls helps young children express thoughts and feelings indirectly. - D. Assessing motor development and problem-solving skills evaluates overall developmental level. Test-taking pearl: Maintain parental presence during initial evaluations of young, anxious pediatric patients. Concept tested: Pediatric clinical assessment techniques Question 3. True or false: SSRIs are the first line treatment for separation anxiety disorder. - A. True - B. False Pause. Answer: B. Why it is correct: Psychotherapy is the established first-line treatment for separation anxiety disorder before considering psychotropic medications. Why the other choices are wrong: - A. Option A is incorrect because SSRIs are second-line or reserved for severe, refractory cases. Test-taking pearl: Always choose psychotherapy over medications as initial therapy for pediatric anxiety disorders. Concept tested: First-line management of separation anxiety disorder Question 4. True or false: Functional capacity can help distinguish separation anxiety disorder from normal developmental fears. - A. True - B. False Pause. Answer: A. Why it is correct: Functional capacity measures how well a child can attend school, participate in peer activities, and manage daily routines away from caregivers, separating pathology from normal development. Why the other choices are wrong: - B. Option B is incorrect because functional impairment is the primary clinical threshold for confirming a diagnosis. Test-taking pearl: Look for functional impairment across settings to confirm a clinical disorder. Concept tested: Differential diagnosis of pediatric anxiety Question 5. The mother of a 5-year-old boy expresses concern about her son, who will be starting school soon. She states that he has always been very anxious to go anywhere without her or her husband, and he will sometimes have major crying fits that often cause him to choke and vomit. The NP replies: - A. Children his age this is normal and will pass with time. - B. We can start a trial of an anti-anxiety medication and reevaluate in two weeks. - C. He should be evaluated for separation anxiety disorder. - D. It is likely that he may have been abused in the past. Pause. Answer: C. Why it is correct: The child demonstrates severe separation distress accompanied by somatic symptoms like choking and vomiting, causing functional impairment that requires a formal diagnostic evaluation. Why the other choices are wrong: - A. Severe crying fits with choking and vomiting represent pathological distress rather than normal development. - B. Prescribing anti-anxiety medication before completing a diagnostic evaluation and trying psychotherapy is inappropriate. - D. Suspecting abuse without clinical indicators or disclosure misdirects the assessment. Test-taking pearl: Evaluate severe somatic separation distress rather than dismissing it as a normal phase. Concept tested: Clinical evaluation of separation anxiety disorder Next Study Step. Review **ADHD, ASD, and Disruptive Behavior** in youth to master the differential diagnosis between neurodevelopmental inattention, oppositional defiance, and anxiety-driven classroom avoidance. Next. Topic. Trauma and the ACE Framework. Quick Answer. Adverse Childhood Experiences (ACEs) create cumulative biological and psychological risk across the lifespan, requiring routine trauma-informed screening in youth. Pediatric PTSD requires symptoms lasting greater than 1 month following trauma exposure, with Trauma-Focused Cognitive Behavioral Therapy (TF-CBT) established as the primary first-line intervention. Bottom Line. - An ACE score of 4 or higher exponentially increases lifetime risk for major depressive disorder, substance use disorders, suicide attempts, and chronic medical illness. - Acute Stress Disorder is diagnosed when post-trauma symptoms last between 3 days and 1 month, whereas PTSD requires symptom persistence for greater than 1 month. - In children 6 years and younger, PTSD manifests through repetitive trauma play, frightening dreams without clear content, social withdrawal, and extreme temper outbursts. - First-line treatment for pediatric PTSD is Trauma-Focused Cognitive Behavioral Therapy (TF-CBT), not psychotropic medication. - SSRIs like fluoxetine (FDA approved for depression at age 8 and older) and escitalopram (FDA approved at age 12 and older) carry an FDA black box warning for increased suicidal ideation in youth under 25. - Suspected child physical or sexual abuse requires immediate mandatory reporting to state Child Protective Services (CPS) regardless of parental consent. - Non-suicidal self-injury (NSSI) like cutting without active suicidal intent does not legally require breaching adolescent confidentiality unless acute safety risk exists. Must Know for Boards. The ACE Framework and Biological Impact. The Adverse Childhood Experiences (ACE) study identifies ten core categories of early adversity across three major domains: abuse (physical, emotional, sexual), neglect (physical, emotional), and household dysfunction (parental mental illness, incarcerated relative, domestic violence, substance abuse, parental divorce). Accumulated childhood stress activates the hypothalamic-pituitary-adrenal (HPA) axis, leading to chronic hypercortisolemia, neuroinflammation, and altered prefrontal cortex development. On board exams, recognize that an ACE score of 4 or more creates a dose-response relationship, dramatically elevating the risk for adolescent substance abuse, severe depression, and adult physical morbidity. Pediatric PTSD Diagnostic Criteria and Timelines. Post-Traumatic Stress Disorder in children and adolescents requires exposure to actual or threatened death, serious injury, or sexual violence through direct experience, witnessing, or learning of trauma to a caregiver. Key diagnostic criteria include: - Duration: Symptoms must persist for more than 1 month. Symptoms lasting 3 days to 1 month represent Acute Stress Disorder. - Intrusion: Intrusive memories, trauma-specific play reenactment, or distressing dreams. Young children often have nightmares without recognizable trauma content. - Avoidance: Persistent avoidance of distressing trauma memories, people, places, or conversations. - Cognition and Mood: Increased negative emotional states, diminished interest in play, detachment from peers, and inability to express positive emotions. - Arousal and Reactivity: Irritability, angry outbursts, hypervigilance, exaggerated startle response, concentration deficits, and sleep disturbance. Clinical Presentation Unique to Youth. Youth rarely present with classic adult flashback descriptions. Instead, look for somatic complaints (stomachaches, headaches), behavioral regression (enuresis, thumb sucking), separation anxiety, or severe aggression. Preschool children express trauma through repetitive play themes where the traumatic event is repeatedly acted out with toys. Signposts and Board Pearls. Safety Alert. If a pediatric or adolescent assessment reveals reasonable suspicion of physical abuse, sexual abuse, or neglect, you must report immediately to Child Protective Services (CPS). Mandated reporting laws override patient confidentiality and do not require parental consent. Board Trap. Do not prescribe benzodiazepines for pediatric trauma or PTSD. Benzodiazepines lack efficacy for PTSD core symptoms and carry significant risks of behavioral disinhibition, cognitive impairment, and physiological dependence in children. First-Line. First-line treatment for pediatric trauma and PTSD is Trauma-Focused Cognitive Behavioral Therapy (TF-CBT). Psychotherapy must be initiated before considering psychotropic medications. Compare and Distinguish. Post-Traumatic Stress Disorder (PTSD) - Think: persistent intrusive and hyperarousal symptoms lasting greater than 1 month - Priority: Trauma-Focused Cognitive Behavioral Therapy (TF-CBT) - Boards are testing: symptom duration threshold of greater than 30 days and psychotherapy as primary care Acute Stress Disorder - Think: severe post-trauma stress reactions lasting between 3 days and 1 month - Priority: psychological first aid, supportive counseling, and safety stabilization - Boards are testing: recognizing symptoms under 1 month before diagnosing full PTSD Sleep Terrors vs PTSD Nightmares in Children - Think: sleep terrors occur in deep NREM sleep during early night with incomplete awakening and no dream recall - Priority: reassure parents that sleep terrors are benign and self-limiting in preschool children - Boards are testing: avoiding unnecessary abuse workups or trauma referrals for typical developmental parasomnias Fitzgerald Sample Questions. Question 1. Katana is a 14-year-old girl seen in your clinic for evaluation because her mother found that she had been using a razor blade to cut her wrist. Which of the following is false regarding parental consent? A) She can receive family planning assistance without parental consent. B) You do not require parental consent before treating a psychiatric condition. C) Most states will allow you to provide information and treatment for substance use disorder without parental consent. D) Providers are not required to report self-harm behaviors, such as cutting, to the child's parents or guardians. Pause. Answer: B Why it is correct: Choice B is a false statement, making it the correct answer to the question. Treating a non-emergent psychiatric condition in a minor legally requires parental or guardian consent in most jurisdictions. Why the other choices fail: - Option A is incorrect because it is a true statement; federal and state laws permit minors to access confidential family planning services without parental consent. - Option C is incorrect because it is a true statement; most state statutes allow adolescents to seek confidential substance use disorder evaluation and treatment without parental notification. - Option D is incorrect because it is a true statement; non-suicidal self-injury (NSSI) like superficial cutting without suicidal intent does not automatically mandate breaching adolescent confidentiality, allowing the clinician to evaluate safety and work toward voluntary parental involvement. Question 2. A mother is worried about her 4-year-old child who has had bad dreams, where the child wakes up in a panicky state during the night with shortness of breath and sweating. In the morning, the child does not remember the dream. What is the PMHNP's best response? A) Reassure the mother that this is a night terror and the child will grow out of it. B) Question the mother about possible childhood sexual abuse and screen for PTSD. C) Educate the mother to wake the child out of sleep and try to console them. D) Ask the mother about snoring and refer the child for a sleep study. Pause. Answer: A Why it is correct: Sleep terrors (night terrors) peak in preschool children aged 3 to 4 years. They feature sudden autonomic arousal, inconsolability during the event, and complete amnesia in the morning. They are benign, self-limiting, and managed with parent reassurance and environment safety. Why the other choices fail: - Option B is incorrect because acute autonomic nighttime awakenings without daytime intrusive symptoms or trauma history reflect normal developmental parasomnias, not sexual abuse or PTSD. - Option C is incorrect because trying to wake a child during a sleep terror increases confusion, panic, and prolonged agitation. - Option D is incorrect because snoring and sleep apnea present with daytime sleepiness and airway resistance, not isolated nocturnal panicky awakenings. Question 3. During an evaluation of a 16-year-old female with substance use disorder, she confides that she is increasingly confused about her sexual orientation. An appropriate action by the PMHNP is to: A) Notify her parents of this finding. B) Routinely screen for depression and suicidality. C) Initiate reparative therapy. D) Initiate SSRI therapy. Pause. Answer: B Why it is correct: Sexual and gender minority adolescents experience elevated rates of minority stress, trauma, depression, and suicidal ideation. Routine screening for mood symptoms and suicide risk is the priority clinical action. Why the other choices fail: - Option A is incorrect because disclosing an adolescent's sexual orientation to parents violates confidentiality and may expose the youth to rejection or safety risks at home. - Option C is incorrect because conversion or reparative therapy is unethical, harmful, and explicitly condemned by all major professional medical organizations. - Option D is incorrect because exploring sexual orientation is a normal developmental process, not a psychiatric pathology requiring antidepressant prescribing. Next Study Step. Review pediatric mood disorders and Disruptive Mood Dysregulation Disorder (DMDD) criteria in Chapter 15 to master the differential diagnosis between chronic pediatric irritability and bipolar disorder. Next. New section. Stimulant Management and Safety Precautions. Topic. Sample Question: Methylphenidate and Tics. Bottom Line Summary. * First-line pharmacotherapy for ADHD in children aged 6 and older consists of **methylphenidate** or **amphetamine** formulations, while behavioral therapy is recommended for children under 5 years of age [1-3]. * Baseline and quarterly monitoring for children on stimulant therapy must include **height**, **weight**, **blood pressure**, and **pulse** [3, 4]. * Recognized potential adverse effects of **methylphenidate** include **loss of appetite**, **weight loss**, **headache**, **insomnia**, and **exacerbation of tic disorders** [5-7]. * **Hypersomnia** is not an adverse effect of stimulant medications source 6. * Approximately 20% of children with ADHD develop a chronic tic disorder independent of medication, while 50% of children with chronic tics or Tourette syndrome have comorbid ADHD [8, 9]. * Tics naturally wax and wane over time, so new or worsening tics may be coincidental or stimulant-induced source 9. * If a child develops new motor tics such as eye blinking or neck jerking two weeks after starting **methylphenidate**, the PMHNP should discontinue the stimulant and switch to **atomoxetine** [10-12]. * High doses of **dextroamphetamine** should be avoided in children with tics, and a rechallenge can be considered if tics persist after stimulant cessation source 9. * Stimulants require caution or avoidance in patients with **hypertension**, **cardiac abnormalities**, **substance use disorder history**, **motor tics**, or **severe anxiety** [13-15]. **Type 2 diabetes** does not require special stimulant caution source 15. High-Yield Concept: Stimulant Management and Tics. Pediatric Psychopharmacology for ADHD. * **First-line**: **Methylphenidate** and **amphetamine** compounds represent the gold standard first-line treatment for pediatric ADHD [2, 4]. Behavioral interventions are first-line for children under 5 years old source 3. * **Safety alert**: Central nervous system stimulants increase dopamine and norepinephrine signaling, which can elevate blood pressure, increase heart rate, suppress appetite, and trigger or worsen motor and vocal tics [4, 8, 9, 13, 14]. * **Safety alert**: Baseline assessment prior to initiating stimulants requires checking cardiac history, vital signs, and growth parameters [3, 4, 13, 14]. Routine quarterly monitoring of **height**, **weight**, **blood pressure**, and **pulse** is mandatory [3, 4]. * **Board trap**: Assuming every new tic during stimulant therapy is a permanent medication toxicity. Tics naturally wax and wane over time source 9. However, if tics emerge or worsen significantly on **methylphenidate**, the board exam expects you to stop the stimulant and switch to **atomoxetine** [11, 12]. * **Board trap**: Thinking **type 2 diabetes** is a contraindication to stimulant therapy. Stimulants do not directly alter glucose regulation and are safe to use in diabetic youth source 15. Managing Stimulant-Induced Tics vs Comorbid Tic Disorders. * **Epidemiology**: Up to 20% of children with ADHD experience chronic tics without any drug exposure source 8. Conversely, 50% of youth with Tourette syndrome or chronic tics have comorbid ADHD [8, 9]. * **Dosing rule**: Avoid high doses of **dextroamphetamine** in children with motor or vocal tics source 9. * **Clinical sequence**: If tics appear after starting **methylphenidate** (such as Ritalin SR), discontinue the stimulant and initiate **atomoxetine** [11, 12]. If tics persist long after stopping the stimulant, a rechallenge or non-stimulant alternative like an alpha-2 adrenergic agonist (**clonidine** or **guanfacine**) can be evaluated [4, 9]. Sample Board Exam Questions. Question 1. When initiating **methylphenidate** therapy for a 9-year-old boy with ADHD, the PMHNP educates the family on the possibility of all of the following potential adverse effects except: - A. **Headache** - B. **Hypersomnia** - C. **Loss of appetite** or **weight loss** - D. **Exacerbation of tic disorder** Pause. Best answer: B. **Hypersomnia** source 6. Why it is correct: **Methylphenidate** is a central nervous system stimulant that promotes wakefulness and arousal, causing **insomnia** rather than **hypersomnia** source 6. Why the other choices are wrong: - A. **Headache** is a recognized, often transient adverse effect during initial stimulant titration source 7. - C. **Loss of appetite** and **weight loss** are frequent catecholamine-mediated adverse effects of stimulants source 7. - D. **Exacerbation of tic disorder** is a well-documented potential adverse effect of **methylphenidate** source 7. Test-taking pearl: Stimulants increase alertness and cause **insomnia**, never **hypersomnia** source 6. Concept tested: **Methylphenidate adverse effect profile** [5-7]. Question 2. An 8-year-old boy recently diagnosed with ADHD is prescribed a **methylphenidate** stimulant, Ritalin SR, as an initial treatment. At the follow-up visit two weeks later, the mother reports some improvement in ADHD symptoms, but she has noticed the development of a tic consisting of eye blinking and neck jerking. The NP recommends: - A. Increasing the dose of **methylphenidate** - B. Switching to **methylphenidate** extended release like Concerta - C. Switching to **atomoxetine** or Strattera - D. Adding **bupropion** to his regimen Pause. Best answer: C. Switching to **atomoxetine** or Strattera [11, 12]. Why it is correct: Developing new motor tics such as eye blinking and neck jerking two weeks after starting **methylphenidate** indicates stimulant-induced tic exacerbation. The correct clinical action is to discontinue the stimulant and switch to **atomoxetine**, a non-stimulant that does not provoke tics [11, 12]. Why the other choices are wrong: - A. Increasing the **methylphenidate** dose will increase dopamine levels further and worsen the motor tics [9, 11]. - B. Switching to Concerta still delivers **methylphenidate** and will continue to exacerbate the tics source 11. - D. Adding **bupropion** does not remove the offending stimulant and is not the primary non-stimulant choice for tic management source 11. Test-taking pearl: When a child develops new motor tics on a stimulant, discontinue the stimulant and switch to **atomoxetine** [11, 12]. Concept tested: **Stimulant-induced tics and non-stimulant management** [8, 9, 11, 12]. Question 3. When considering management of ADHD in a 15-year-old, the use of a stimulant medication should be avoided or used with caution in the presence of which of the following? (Select all that apply) - A. **Hypertension** - B. **Cardiac abnormality** - C. **Type 2 diabetes** - D. Prior history of **substance use disorder** - E. Presence of **motor tics** - F. History of **anxiety** or **agitated states** Pause. Best answer: A, B, D, E, F [13-15]. Why it is correct: Stimulants require caution or avoidance in **hypertension** and **cardiac abnormalities** due to sympathomimetic cardiovascular effects, in **substance use history** due to misuse potential, in **motor tics** due to tic exacerbation, and in **anxiety** or **agitated states** due to heightened CNS arousal [13-15]. Why the other choices are wrong: - C. **Type 2 diabetes** is incorrect because stimulants do not directly disrupt glycemic control and do not require avoidance or special caution source 15. Test-taking pearl: Diabetes is safe for stimulant therapy, but cardiovascular disease, tics, substance abuse, and severe anxiety require caution [13-15]. Concept tested: **Stimulant precautions and contraindications** [13-15]. Next Study Step. Review non-stimulant options for pediatric ADHD, specifically alpha-2 adrenergic agonists (**clonidine** and **guanfacine**), to master second-line management for comorbid tics, insomnia, and behavioral disruption source 4. Next. End of this drive.